Could a simple mineral ease migraines faster in the ER?
NCT ID NCT06904287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving magnesium along with the standard migraine drug prochlorperazine reduces pain more than the drug alone. About 100 adults with migraines in the emergency department will receive either the combination or a placebo. Researchers will measure pain changes at 30, 45, and 60 minutes after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- magnesium
- What this could lead to
- If it works, this could give emergency doctors a simple, safe way to relieve migraine pain more quickly.
- What could go wrong
- This is a small, early-phase trial with only 100 participants. The benefit may be small or not apply to all migraine types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advocate Christ Medical Center Emergency Department
RECRUITINGOak Lawn, Illinois, 60453, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?